Inception Return
(6/10/2013)
|
7.52 %
|
YTD Return
|
11.96 %
|
|
NAVPS
(1/13/2025)
|
$14.18
|
Change
|
$0.00 / 0.00 %
|
|
Growth of $10,000
(As of December 31, 2024)
|
MER
|
1.98 %
|
Assets ($mil)
|
$448.17
|
Rank (1Yr)
|
1169/1721
|
Std Dev (3Yr)
|
10.29 %
|
Volatility Ranking (3Yr)
|
5/10
|
RRSP Eligibility
|
Yes
|
Load
|
Back Fee Only
|
Max Front End
|
5.00 %
|
Max Back End
|
-
|
Sales Status
|
Open
|
|
Objective
The fundamental investment objective of the Pool is to seek to generate income and capital appreciation primarily through exposure to a diversified portfolio primarily consisting of dividend paying equity and fixed income securities. The Pool will also invest its assets in equity, fixed income, mutual fund or exchange-traded fund securities. The fundamental investment objective of the Fund cannot be changed without the approval of investors who own securities in the Fund.
|
Fund Manager
Manulife Investment Management Limited
Portfolio Manager
Manulife Investment Management Limited
Sub-Advisor
Michael J. Mattioli, Manulife Investment Management (US) LLC
Daniel S. Janis III, Manulife Investment Management (US) LLC
Thomas C. Goggins, Manulife Investment Management (US) LLC
Sandy Sanders, Manulife Investment Management (US) LLC
|
Asset Allocation
(As of November 30, 2024)
|
Sector Allocation
(As of November 30, 2024)
|
Geographic Allocation
(As of November 30, 2024)
|
Top 10 Holdings
Name | Asset | Sector | Geographic | Percent |
Manulife Global Fixed Income Private Trust Adv | Foreign Bonds | Fixed Income | Multi-National | 39.86% |
US Dollar | Cash and Equivalents | Cash and Cash Equivalent | United States | 2.92% |
Apple Inc | US Equity | Technology | United States | 2.92% |
Amazon.com Inc | US Equity | Consumer Services | United States | 2.62% |
Cheniere Energy Inc | US Equity | Energy | United States | 2.57% |
Crown Castle International Corp | US Equity | Real Estate | United States | 2.41% |
Anthem Inc | US Equity | Healthcare | United States | 2.35% |
Comcast Corp Cl A | US Equity | Telecommunications | United States | 2.21% |
GSK plc - ADR | International Equity | Healthcare | European Union | 1.97% |
Avantor Inc | US Equity | Healthcare | United States | 1.91% |
Performance Data
(As of December 31, 2024)
|
Return (%)
|
Annualized Return (%)
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
Fund
|
-1.20
|
0.80
|
5.94
|
11.96
|
11.96
|
4.78
|
6.39
|
6.42
|
Benchmark
|
0.17
|
3.26
|
8.97
|
17.48
|
17.48
|
5.06
|
6.53
|
7.49
|
Quartile Ranking
|
3
|
4
|
4
|
3
|
3
|
1
|
2
|
1
|
Calendar Return (%)
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
Fund
|
11.96
|
13.84
|
-9.74
|
13.63
|
4.28
|
19.93
|
-9.83
|
9.79
|
9.31
|
5.29
|
Benchmark
|
17.48
|
11.69
|
-11.62
|
6.48
|
11.12
|
12.26
|
2.68
|
8.66
|
2.39
|
17.05
|
Quartile Ranking
|
3
|
1
|
2
|
1
|
4
|
1
|
4
|
1
|
1
|
2
|